Your constraint first, our capacity second
Three buyers of the same intermediate want different things. A Phase III programme needs change control. A generic manufacturer needs batch ten to match batch one. An academic group needs to buy 5 g and get a compliant invoice. Different constraints, different answers.
01
Innovators & biotech
From target selection to IND, time is the expensive input. What this stage needs is not the most elegant route but the fastest batch with complete data.
Your likely situation
- Samples needed now, not in three months
- Structures cannot leak
- Data must feed straight into our technical file
- No appetite for a new supplier at scale-up
Make it work, then make it good
The first batch targets a working route with complete data. Yield and cost optimisation wait for batch two — time is not traded for elegance.
Confidentiality up front
A mutual NDA can be signed at assessment, covering the structure, the route and the existence of the project. Information is released in tiers.
Data as documentation
Records are kept to a traceable standard from the first lab batch: batch records, raw spectra, methods and impurity assignment. Later method transfer or follow-up studies need no repeat experiments.
One chain through scale-up
From grams to kilograms without changing hands, so parameters and impurity profile stay continuous and the background never has to be re-explained.
02
Generics & formulation
At commercial stage the real risk is not price but change. A new raw material source or a different crystallization solvent can force dissolution work to restart at the formulation end.
Your likely situation
- Batch-to-batch variation in particle size or polymorph
- Silent changes in raw material source
- Changes without written record
- Cost pressure without quality loss
Parameters locked
Once the process is fixed, critical parameters are written into the batch record and operating windows are expressed as a design space — not left to operator feel.
Change control
Route, source, critical parameter and method changes are managed at three levels; major changes require written client approval before execution.
Batch trending
Quality data trended across consecutive batches. Drift triggers an investigation of materials and equipment before release — never a retest.
Cost lives in the process
Cost reduction comes from solvent recovery, step consolidation and yield, not from cutting tests or buying cheaper raw material.
03
Academia & CROs
Academic purchasing does not work like pharma procurement: small amounts, odd SKUs, invoices, reimbursement paperwork, CAS lookup. These are not small things — if they fail, the buyer goes elsewhere.
Your likely situation
- Only 5 g needed, and no one will supply it
- Cannot find the CAS
- No COA, so goods cannot be booked in
- Contract and invoicing friction
Small pack sizes
Catalogue items from 5 g, bottled, with COA and SDS included so materials can be booked straight into stores.
Search by CAS
The whole catalogue is searchable by CAS, Chinese or English name and product code. Different salts and protecting groups are separate entries.
Compliant process
Contracts, invoices and reimbursement documentation supported, including corporate transfer and university procurement workflows.
Technical answers
Solubility, stability and storage questions are answered by the technical team, not relayed through sales.
04
Export & trading
Cross-border purchases fail on paperwork more often than on quality. A missing English COA, non-compliant packaging or a wrong dangerous goods declaration can stop a shipment at the port.
Your likely situation
- Document format and language rejected
- Packaging and DG declaration not compliant
- Time zone delays
- Supplier qualifications unverifiable
English documentation
COA, SDS and specification sheets in English, formatted to buyer requirements, with third-party testing arranged where needed.
Packaging and declarations
UN-compliant packaging selected by material, MSDS and declaration elements supplied for dangerous goods, coordination with forwarders on booking and customs.
Time zone handling
Replies within one business day, with agreed fixed communication windows for urgent matters so the time difference never becomes a week.
Transparent qualifications
Certificates we can supply, audit arrangements and regulatory status stated as they are. We do not promise documents we cannot issue.
By stage
What each stage is actually judged on
The same supplier is measured against completely different criteria before preclinical and at commercial stage. The table sets out what we focus on at each.
- Discovery
- mg–g
- Catalogue availability, purity, speed
- Catalogue item or rapid custom batch, COA included
- Preclinical
- 10 g–1 kg
- Complete structure confirmation, initial impurity assignment
- Lab batch with full spectra
- Phase I–II
- 1–50 kg
- Reproducible process, batch consistency, complete documents
- Kilogram batch with process package
- Phase III
- 50 kg–ton
- Scale-up robustness, change control, audit readiness
- Pilot batch with audit support
- Commercial
- ton–annual
- Supply continuity, cost, advance change notice
- Framework agreement with annual scheduling
Engagement
Four ways in, one starting point
Whichever route you take, the first step is the same technical assessment. What differs is the depth of commitment.
Catalogue supply
01Listed products ordered against published pack sizes. Suited to screening, lab work and urgent replenishment.
Custom synthesis
02Non-catalogue molecules quoted from structure and quantity. The compound is delivered with reproducible chemistry and complete data.
Framework agreement
03Fixed specification, price band and capacity priority, scheduled quarterly or annually. Suited to launched or near-launch products.
Technology transfer
04Scale-up of a client process, or transfer of our process into a client plant, with on-site technical support.
Tell us the stage you are at
Molecule, quantity and stage are enough for us to respond with a stage-appropriate plan rather than a generic price list.